跳至主要内容
临床试验/NCT04149028
NCT04149028已完成不适用

Platelet Rich Plasma Injection Into Ovary of Patients With Premature Ovarian Insufficiency

Tanta University1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2019年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
1
主要终点
Resumption of ovarian folliclugenesis

研究概览

简要总结

All encountered cases with POI will be assessed and examined then investigated. Eligible cases will be included in the study

详细描述

Patients will be subjected to injection of autologous PRP inside the ovary about 0.5-1 mml by laparoscopy

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Premature ovarian insufficiency diagnosed by:
  • •FSH> 40 Amenorrhea Menopuasal symptoms Infertility

排除标准

  • •Refusal to participate Secondary POI due chemotherapy, surgery, or radiotherapy Previous treatment with PRP

研究组 & 干预措施

PRP injection

Experimental

injection of PRP inside ovary by the assistance of laparoscopy

干预措施: PRP injection inside the ovary by laparoscoy. The injection volume is 2 ml (Procedure)

结局指标

主要结局

Resumption of ovarian folliclugenesis

时间窗: 3-6 months

Assessment of the presence of oocytes by trans vaginal ultrasound on day 3

Resumption of ovarian hormonal function

时间窗: 3-6 months

Measurement of Estradiol level on Day 3 of cycle

次要结局

  • Resumption of menstruation(3-6 months)
  • Fertility potential(3-6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ayman S Dawood, MD

Lecturer of Obstetrics and gynecology

Tanta University

研究点 (1)

Loading locations...

相似试验